- Home
- AARD vs NIU Comparison
AARD vs NIU Comparison
Compare AARD & NIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AARD | NIU |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 281.1M | 275.6M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | AARD | NIU |
|---|---|---|
| Price | $3.81 | $2.78 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 1 |
| Target Price | ★ $19.63 | $3.50 |
| AVG Volume (30 Days) | 487.6K | ★ 638.7K |
| Earning Date | 03-23-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $25.84 |
| Revenue Next Year | $2,107.17 | $14.65 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.35 | $2.71 |
| 52 Week High | $17.94 | $5.67 |
Technical Indicators
Market Signals| Indicator | AARD | NIU |
|---|---|---|
| Relative Strength Index (RSI) | 22.54 | 37.20 |
| Support Level | N/A | N/A |
| Resistance Level | $6.19 | $3.43 |
| Average True Range (ATR) | 0.38 | 0.23 |
| MACD | 0.14 | -0.06 |
| Stochastic Oscillator | 17.29 | 7.21 |
Price Performance
Historical ComparisonAbout AARD Aardvark Therapeutics Inc.
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About NIU Niu Technologies
Niu Technologies designs, manufactures and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycle, mopeds and bicycle series, including the NQi, MQi, UQi, F series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.